Cargando…
Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investigated the e...
Autores principales: | Park, Ji-Hye, Yoo, Chungkwon, Chung, Hyun Woo, Kim, Yong Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160208/ https://www.ncbi.nlm.nih.gov/pubmed/34045600 http://dx.doi.org/10.1038/s41598-021-90696-4 |
Ejemplares similares
-
The anterior scleral thickness in eyes with primary open-angle glaucoma
por: Yan, Xiaoqin, et al.
Publicado: (2022) -
Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
por: Kocabeyoglu, Sibel, et al.
Publicado: (2015) -
Central Corneal Thickness in Primary Angle Closure and Open Angle Glaucoma
por: Moghimi, Sasan, et al.
Publicado: (2014) -
Effect of Topical Prostaglandin Analogue Therapy on Central Corneal Thickness: A Systematic Review
por: Kim, Jae-Yun, et al.
Publicado: (2022) -
Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011)